Ellipsis Health, the pioneering AI Case Manager company transforming the landscape of healthcare management, has proudly announced that it has successfully raised $38,000,000 in its latest funding round. This momentous achievement not only underscores the market’s growing confidence in Ellipsis Health’s cutting-edge technology but also sets the stage for a revolutionary leap forward in how healthcare providers manage patient cases. The company, which leverages advanced artificial intelligence to bring efficiency and precision to case management, will strategically invest the newly raised capital to further its innovative research and development efforts. With the infusion of funds, Ellipsis Health is poised to expand its product portfolio, refine its AI-driven algorithms, and scale operations to meet the increasing demand for smarter, more efficient healthcare solutions. In addition, the funding will enable the company to bolster its team with top industry talent, improve its platform’s interoperability with existing health systems, and explore new market opportunities that can drive widespread adoption of AI technology in medical case management. By focusing on enhancing user experience and streamlining the administrative burdens faced by healthcare professionals, Ellipsis Health aims to not only deliver cost-effective outcomes for providers but also to improve patient care overall. This funding milestone reinforces the company’s commitment to being at the forefront of technological innovation in healthcare, ensuring that its solutions remain robust, secure, and adaptable in a rapidly evolving industry landscape. The future certainly looks bright for Ellipsis Health, as it continues to push the envelope in harnessing AI to revolutionize case management across the healthcare continuum.
Ellipsis Health Raises $38M in Series A to Revolutionize AI Case Management Solutions
Recently funded · $38.0M Series aTechnology, Information and Internet
Get the full Ellipsis Health company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
